BLLN
BillionToOne, Inc. (BLLN) is rated C+ (2.8/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B+); its weakest is Value (D). The rating has held at C+ for 15 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-17 | D (1.2) | B (3.2) | B+ (3.7) | B (3.5) | C+ (2.6) | C+ (2.8) |
| 2026-11-10 | D- (1.1) | C+ (2.8) | B+ (3.7) | B- (3.1) | C+ (2.6) | C+ (2.6) |
| 2026-11-03 | D- (1.0) | C+ (2.8) | B+ (3.7) | B- (2.9) | C+ (2.7) | C+ (2.6) |
| 2026-10-27 | D- (1.0) | C+ (2.8) | B+ (3.7) | B- (3.0) | C+ (2.6) | C+ (2.6) |
| 2026-10-20 | D- (1.0) | C+ (2.8) | B+ (3.7) | C (2.5) | C+ (2.6) | C+ (2.5) |